BiotechTube
Nth Analytics

Nth Analytics

Boston, United States· Est.
nthanalytics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nth Analytics is a privately held, boutique CRO founded in 2019, though its leadership claims over 25 years of collective industry service. It provides high-expertise services in statistical programming, clinical data analysis, and regulatory compliance (e.g., FDA submissions via CDISC/Pinnacle21). The company operates with a deliberate small-team model, targeting niche, high-value assignments for biopharma clients. Its core value proposition lies in deep technical expertise in SAS and data standards, aiming to ensure precision and technological leadership in clinical data analytics.

AI / Machine LearningDigital Health

Technology Platform

Expert-driven application of SAS programming, CDISC data standards (SDTM, ADaM), and statistical methodologies for clinical trial analysis and regulatory submissions. Claims expertise in AI/ML applications within this domain.

Opportunities

Growing complexity in clinical trials and stringent regulatory requirements drive demand for specialized statistical and data standards expertise.
The expansion of AI/ML in clinical data analysis presents an area to develop and market advanced analytical services.
The boutique model is attractive to biotechs seeking high-touch, expert support for mission-critical submissions.

Risk Factors

High dependence on a few key personnel and a limited number of clients creates vulnerability.
The industry's potential shift away from SAS towards open-source languages could challenge the core technical expertise.
Competition from large CROs and internal sponsor capabilities pressures market share and pricing.

Competitive Landscape

Nth Analytics competes in the niche segment of boutique biostatistical CROs. Primary competitors include other small expert firms and the specialized departments of large, full-service CROs (e.g., IQVIA, Parexel, PPD). Its differentiation is a deep, focused expertise in SAS and CDISC, offered by a small, senior team, contrasting with the broader but potentially less specialized services of larger players.

More companies in Digital Health & Biotech SaaS →More companies in United States →